ANDA 76311, held by Accord Hlthcare. Topiramate.
As of Nov 15, 2026, ANDA 76311 (Topiramate), held by Accord Hlthcare, was first approved by FDA on Mar 27, 2009, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 27, 2009 | Original application | Approved | None posted |
| Topiramate25MG · tablet;oral | Topiramate | Rx |
| Topiramate50MG · tablet;oral | Topiramate | Rx |
| Topiramate100MG · tablet;oral | Topiramate | Rx |
| Topiramate200MG · tablet;oral | Topiramate | Rx |
| Sep 24, 2014 | Supplement 3Labeling | Approved | None posted |
| Jun 14, 2011 | Supplement 2REMS | Approved | None posted |
| Jan 28, 2010 | Supplement 1Labeling | Approved | None posted |
| Mar 27, 2009 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters